Table 2 Correlations between sB7-H3 level and clinicopathological characteristics
From: Clinical significance of serum soluble B7-H3 in patients with osteosarcoma
Characteristics | Total number | sB7-H3 | p value | |
|---|---|---|---|---|
High | Low | |||
Age | ||||
≤ 10 | 19 | 14 | 4 | 0.395 |
> 10 | 18 | 13 | 6 | |
Gender | ||||
Male | 22 | 16 | 6 | 0635 |
Female | 15 | 11 | 4 | |
Site | ||||
Femur | 24 | 18 | 6 | 0.887 |
Tibia | 9 | 6 | 3 | |
Others | 4 | 3 | 1 | |
Size (cm) | ||||
≥ 5 | 21 | 15 | 6 | 0.555 |
< 5 | 16 | 12 | 4 | |
Ennecking stage | ||||
I | 12 | 6 | 6 | 0.037 |
II | 16 | 12 | 4 | |
III | 9 | 9 | 0 | |
Histologic type | ||||
Osteoblastic | 27 | 18 | 9 | 0.343 |
Chondroblastic | 8 | 7 | 1 | |
Others | 2 | 2 | 0 | |
Differentiation status | ||||
High | 23 | 13 | 10 | 0.003 |
Low | 14 | 13 | 1 | |
Pulmonary metastasis | ||||
Yes | 10 | 9 | 1 | 0.024 |
No | 27 | 17 | 10 | |
Response to chemotherapy | ||||
Good | 17 | 9 | 8 | 0.015 |
Poor | 20 | 18 | 2 | |